Volume 10 Issue 5
Sep.  2019
Turn off MathJax
Article Contents
Branch of Organ Transplantation of Chinese Medical Association. Technical specification for the diagnosis and treatment on rejection of renal transplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(5): 505-512. doi: 10.3969/j.issn.1674-7445.2019.05.008
Citation: Branch of Organ Transplantation of Chinese Medical Association. Technical specification for the diagnosis and treatment on rejection of renal transplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(5): 505-512. doi: 10.3969/j.issn.1674-7445.2019.05.008

Technical specification for the diagnosis and treatment on rejection of renal transplantation (2019 edition)

doi: 10.3969/j.issn.1674-7445.2019.05.008
  • Received Date: 2019-06-28
    Available Online: 2021-01-19
  • Publish Date: 2019-09-15
  • loading
  • [1]
    NANKIVELL BJ, ALEXANDER SI. Rejection of the kidney allograft[J]. N Engl J Med, 2010, 363(15):1451-1462. DOI: 10.1056/NEJMra0902927.
    [2]
    BROECKER V, MENGEL M. The significance of histological diagnosis in renal allograft biopsies in 2014[J]. Transpl Int, 2015, 28(2):136-143. DOI: 10.1111/tri.12446.
    [3]
    JORDAN SC, PESCOVITZ MD. Presensitization: the problem and its management[J]. Clin J Am Soc Nephrol, 2006, 1(3):421-432. doi: 10.2215/CJN.01651105
    [4]
    STEGALL MD, GLOOR J, WINTERS JL, et al. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody[J]. Am J Transplant, 2006, 6(2):346-351. doi: 10.1111/j.1600-6143.2005.01178.x
    [5]
    EL-ZOGHBY ZM, STEGALL MD, LAGER DJ, et al. Identifying specific causes of kidney allograft loss[J]. Am J Transplant, 2009, 9(3):527-535. DOI: 10.1111/j.1600-6143.2008.02519.x.
    [6]
    SELLARÉS J, DE FREITAS DG, MENGEL M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence[J]. Am J Transplant, 2012, 12(2):388-399. DOI: 10.1111/j.1600-6143.2011.03840.x.
    [7]
    WIEBE C, GIBSON IW, BLYDT-HANSEN TD, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant[J]. Am J Transplant, 2012, 12(5):1157-1167. DOI: 10.1111/j.1600-6143.2012.04013.x.
    [8]
    NANKIVELL BJ. Clinical allograft rejection syndromes in kidney transplantation[M]// KIRK AD, KNECHTLE SJ, LARSEN CP, et al. Textbook of organ transplantation. Hoboken: John Wiley & Sons Ltd, 2014.
    [9]
    中华医学会器官移植学分会, 中国医师协会器官移植医师分会.中国肾移植排斥反应临床诊疗指南(2016版)[J].器官移植, 2016, 7(5):332-338. DOI: 10.3969/j.issn.1674-7445.2016.05.002.

    Branch of Organ Transplantation of Chinese Medical Association, Branch of Organ Transplant Physician of Chinese Medical Doctor Association. Guideline on clinical diagnosis and treatment for rejection of renal transplantation in China(2016 edition)[J]. Organ Transplant, 2016, 7(5): 332-338. DOI: 10.3969/j.issn.1674-7445.2016.05.002.
    [10]
    YAICH S. ABO-incompatible kidney transplantation[J]. Saudi J Kidney Dis Transpl, 2013, 24(3):463-472. doi: 10.4103/1319-2442.111009
    [11]
    MURAMATSU M, GONZALEZ HD, CACCIOLA R, et al. ABO incompatible renal transplants: good or bad?[J]. World J Transplant, 2014, 4(1):18-29. DOI: 10.5500/wjt.v4.i1.18.
    [12]
    JALALZADEH M, MOUSAVINASAB N, PEYROVI S, et al. The impact of acute rejection in kidney transplantation on long-term allograft and patient outcome[J]. Nephrourol Mon, 2015, 7(1):e24439. DOI: 10.5812/numonthly.24439.
    [13]
    RANDHAWA P. T-cell-mediated rejection of the kidney in the era of donor-specific antibodies: diagnostic challenges and clinical significance[J]. Curr Opin Organ Transplant, 2015, 20(3):325-332. DOI: 10.1097/MOT.0000000000000189.
    [14]
    ZHANG RB. Clinical management of kidney allograft dysfunction[J]. Open J Organ Transpl Surg, 2014, 4(2): 7-14. DOI: 10.4236/ojots.2014.42002.
    [15]
    GABER AO, FIRST MR, TESI RJ, et al. Results of the double-blind, randomized, multicenter, phase Ⅲ clinical trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes after renal transplantation[J]. Transplantation, 1998, 66(1):29-37. doi: 10.1097/00007890-199807150-00005
    [16]
    MCDONALD S, RUSS G, CAMPBELL S, et al. Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome[J]. Am J Transplant, 2007, 7(5):1201-1208. doi: 10.1111/j.1600-6143.2007.01759.x
    [17]
    Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients[J]. Am J Transplant, 2009, 9(Suppl 3): S1-S155. DOI: 10.1111/j.1600-6143.2009.02834.x.
    [18]
    SALVADORI M, BERTONI E. Acute antibody-mediated rejection in kidney transplantation: clinical and therapeutic aspects[J]. J Nephrol Ther, 2013, 4(1):146. DOI: 10.4172/2161-0959.1000146.
    [19]
    FARKASH EA, COLVIN RB. Diagnostic challenges in chronic antibody-mediated rejection[J]. Nat Rev Nephrol, 2012, 8(5):255-257. DOI: 10.1038/nrneph.2012.61.
    [20]
    SIS B, HALLORAN PF. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection[J]. Curr Opin Organ Transplant, 2010, 15(1):42-48. DOI: 10.1097/MOT.0b013e3283352a50.
    [21]
    HIDALGO LG, SIS B, SELLARES J, et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection[J]. Am J Transplant, 2010, 10(8):1812-1822. DOI: 10.1111/j.1600-6143.2010.03201.x.
    [22]
    SIS B, MENGEL M, HAAS M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups[J]. Am J Transplant, 2010, 10(3):464-471. DOI: 10.1111/j.1600-6143.2009.02987.x.
    [23]
    COLVIN RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis[J]. J Am Soc Nephrol, 2007, 18(4):1046-1056. doi: 10.1681/ASN.2007010073
    [24]
    ALLEN U, HUMAR A, LIMAYE A, et al. Discipline of transplant infectious diseases (ID). foreword[J]. Am J Transplant, 2009, 9(Suppl 4): S1-S2. DOI: 10.1111/j.1600-6143.2009.02886.x.
    [25]
    TERASAKI PI, OZAWA M. Predicting kidney graft failure by HLA antibodies: a prospective trial[J]. Am J Transplant, 2004, 4(3):438-443. doi: 10.1111/j.1600-6143.2004.00360.x
    [26]
    DJAMALI A, KAUFMAN DB, ELLIS TM, et al. Diagnosis and management of antibody-mediated rejection: current status and novel approaches[J]. Am J Transplant, 2014, 14(2): 255-271. DOI: 10.1111/ajt.12589.
    [27]
    VALENZUELA NM, REED EF. Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies[J]. J Clin Invest, 2017, 127(7): 2492-2504. DOI: 10.1172/JCI90597.
    [28]
    HARIRIAN A. Current status of the evaluation and management of antibody-mediated rejection in kidney transplantation[J]. Curr Opin Nephrol Hypertens, 2015, 24(6): 576-581. DOI: 10.1097/MNH.0000000000000167.
    [29]
    MORATH C, ZEIER M. Transplantation: molecular diagnosis of kidney transplant rejection[J]. Nat Rev Nephrol, 2014, 10(8): 429-430. DOI: 10.1038/nrneph.2014.106.
    [30]
    WILFLINGSEDER J, REINDL-SCHWAIGHOFER R, SUNZENAUER J, et al. MicroRNAs in kidney transplantation[J]. Nephrol Dial Transplant, 2015, 30(6):910-917. DOI: 10.1093/ndt/gfu280.
    [31]
    LUCAS JG, CO JP, NWAOGWUGWU UT, et al. Antibody-mediated rejection in kidney transplantation: an update[J]. Expert Opin Pharmacother, 2011, 12(4):579-592. DOI: 10.1517/14656566.2011.525219.
    [32]
    SINGH N, PIRSCH J, SAMANIEGO M. Antibody-mediated rejection: treatment alternatives and outcomes[J]. Transplant Rev (Orlando), 2009, 23(1):34-46. DOI: 10.1016/j.trre.2008.08.004.
    [33]
    PUTTARAJAPPA C, SHAPIRO R, TAN HP. Antibody-mediated rejection in kidney transplantation: a review[J]. J Transplant, 2012:193724. DOI: 10.1155/2012/193724.
    [34]
    KIM M, MARTIN ST, TOWNSEND KR, et al. Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options[J]. Pharmacotherapy, 2014, 34(7):733-744. DOI: 10.1002/phar.1426.
    [35]
    NANKIVELL BJ, BORROWS RJ, FUNG CL, et al. The natural history of chronic allograft nephropathy[J]. N Engl J Med, 2003, 349(24):2326-2333. doi: 10.1056/NEJMoa020009
    [36]
    HEEMANN U, LUTZ J. Pathophysiology and treatment options of chronic renal allograft damage[J]. Nephrol Dial Transplant, 2013, 28(10):2438-2446. DOI: 10.1093/ndt/gft087.
    [37]
    BHATTI AB, USMAN M. Chronic renal transplant rejection and possible anti-proliferative drug targets[J]. Cureus, 2015, 7(11): e376. DOI: 10.7759/cureus.376.
    [38]
    TANABE K, INUI M. Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantation[J]. Clin Transplant, 2013, 27(Suppl 26):2-8. DOI: 10.1111/ctr.12260.
    [39]
    TAIT BD, SÜSAL C, GEBEL HM, et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation[J]. Transplantation, 2013, 95(1):19-47. DOI: 10.1097/TP.0b013e31827a19cc.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1206) PDF downloads(317) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return